Subscribe to our mailings!

Did you know?

September 16, 2019

Bacteria Root Cause of Alzheimer’s, Stroke and Diabetes (New Study)

Posted By: TreehillPartners
In: Did you know?, Drug Development

A record share of all deaths around the world are attributed to Alzheimer's, varieties of cancer and diabetes. Anecdotal research suggests the number has reached a striking 90% e.g. in the United Kingdom. For decades, the best in class medical professionals summed up these diseases are triggered by bad personal habits by patients such...

August 30, 2024

Long-term perspectives on new drug classes – Ali Pashazadeh, Treehill Partners CEO, quoted in Endpoints News

Posted By: TreehillPartners
In: Drug Development

July 19, 2024

Too Much Data: a Burden or a Blessing? – Clinical Trials Arena Article Quote

Posted By: TreehillPartners
In: Drug Development

July 18, 2024

Who Is Driving The Bus?

Posted By: TreehillPartners
In: Drug Development

July 15, 2024

Improving Communication – The Relationship Between Biotech And Pharma. InVivo / Citeline Commercial Podcast

Posted By: TreehillPartners
In: Business Development & Licensing, Dealmaking, Drug Development

July 10, 2024

Transparency vs. Innovation: The Challenge Of Balancing Clinical Trial Disclosure With IP Protection. Treehill Partners CEO Ali Pashazadeh in Citeline TrialScope keynote speech.

Posted By: TreehillPartners
In: Drug Development

July 25, 2019

World Female Cancer Trends

Posted By: TreehillPartners
In: Did you know?, Drug Development

More women are being diagnosed with and dying from breast cancer, reported the International Agency for Research on Cancer (IARC) in June 2019. Experts are now calling for greater attention to prevention and control measures, in order to offset drivers including ageing population and lifestyle changes which pushed breast cancer to...

June 20, 2024

Challenging Research Models to Improve Health Equity – Biospace Podcast

Posted By: TreehillPartners
In: Drug Development

June 13, 2024

Biopharma Outsourcing Analogs: From Cars To Eggs – Outsourced Pharma Chief Editor Interview

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

June 7, 2024

Drug Development Needs More Focus On Profitability – Outsourced Pharma Chief Editor Interview Part II

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

June 4, 2024

The Impact of Clinical Trial Disclosure on IP & Patents – Citeline Event Keynote Speech

Posted By: TreehillPartners
In: Drug Development

June 3, 2024

BIO International 2024 to Focus on Partnerships Amid New Biosecure Bill

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

July 20, 2019

RESCUE: CRISPR’s Newest Revolution

Posted By: TreehillPartners
In: Did you know?, Drug Development

Medical research capacity to isolate genetic mutations responsible for disease have been revolutionized through the innovation of CRISPR technology.Comprising an expanding set of tools, the technology behind CRISPR manipulates individual genes (and gene expression) by isolating DNA with Cas9 and Cas12 enzymes and isolating RNA...

May 27, 2024

Aligning Drug Development With Commercial Goals – Drug Discovery & Development Interview

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

May 20, 2024

Clinical Trial Awareness Day – BioPharma Reporter Interview

Posted By: TreehillPartners
In: Drug Development

May 13, 2024

European Oncology Attracts Big Pharma

Posted By: TreehillPartners
In: Dealmaking

May 6, 2024

Don’t Blame The Molecule, You May Be The Problem – Outsourced Pharma Chief Editor Interview

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

March 11, 2024

Roundtable: Drug Pricing and Patient Cost

Posted By: TreehillPartners
In: Drug Development

July 18, 2019

Global 3D and 4D BioPrinting Innovation

Posted By: TreehillPartners
In: Did you know?, Drug Development

January 16, 2024

What Does 2024 Hold For Biopharma? Treehill Partners featured in Scrip

Posted By: TreehillPartners
In: Uncategorized

December 19, 2023

Development Success in a Troubling Economic Environment – Medicine Maker Interview

Posted By: TreehillPartners
In: Drug Development

November 22, 2023

Interview: Treehill Partners’ Ali Pashazadeh on How to Improve Clinical Trial Design

Posted By: TreehillPartners
In: Drug Development

November 20, 2023

Fosun Pharma USA and Treehill Partners launch joint efforts for capital investments in biopharma space

Posted By: TreehillPartners
In: Dealmaking

October 17, 2023

Treehill Partners launches novel service aimed at optimizing the biotech drug development process and fostering closer collaboration between key stakeholders

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

June 4, 2019

Key 2019 World Health Industry Trends

Posted By: TreehillPartners
In: Did you know?

September 19, 2023

Korean Biotech on the Global Stage (Webinar Syneos Health / Treehill Partners)

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

July 20, 2023

Biotech Value Creation (Podcast Syneos Health / Treehill Partners)

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

May 11, 2023

New Opportunities for Value Creation: How Biotechs Can Succeed in an Increasingly Competitive Market (Webinar Syneos Health / Treehill Partners)

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

November 17, 2022

Illiquid Gold: Creative Dealmaking in Biotech (Webinar Evaluate / Treehill Partners)

Posted By: TreehillPartners
In: Business Development & Licensing, Dealmaking

April 28, 2022

Innovation Potential in Mental Health

Posted By: TreehillPartners
In: Drug Development, Strategy & Corporate Development

Rising awareness and emergence of differentiated solutions for multiple psychiatric and mental health conditions is an ongoing theme of innovation in pharma but also adjacent and “convergence” fields in healthcare. Increasing incidence, certainly exacerbated by lockdowns and other measures implemented to curtail the spread of COVID-19, and the significant lack of innovation in the past represent the key ingredients for a resurgence, which is currently emerging.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.